BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 5, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 29, 2003
View Archived Issues
No blood pressure effects found for statins in a "real-life" cohort of hypertensive patients
Read More
Novel antiallergic and antiinflammatory agents in Sumitomo pipeline
Read More
Shionogi presents new MMP inhibitors for COPD and other uses
Read More
Sodium channel blockers with analgesic activity identified at ICAgen
Read More
Bayer claims MKK4 and MKK7 inhibitors for inflammatory and immune disorders
Read More
Four series of analgesic agents patented by Gruenenthal researchers
Read More
Menarini scientists prepare and test novel tachykinin NK2 antagonists
Read More
Novel GSK-3beta inhibitors in early development at Janssen
Read More
Pioglitazone is well tolerated and improves the symptoms of nonalcoholic steatohepatitis
Read More
Good gastrointestinal safety profile reported for lumiracoxib in osteoarthritis
Read More
Evidence of clinical activity for rosiglitazone in Crohn's disease
Read More
New data on the effects of GI-181771 on the gastric function of humans
Read More
Atlizumab effective and well tolerated in refractory Crohn's disease
Read More
Ro-64-6198, an ORL1 agonist, inhibits citric acid-induced cough in guinea pigs
Read More
Rifalazil more effective than vancomycin against C. difficile infection in hamsters
Read More
Novel coxib R-109339 effective in a mouse model of adenomatous polyposis
Read More
AZD-3582 induces fewer ulcers as compared to naproxen in a rat refeeding model
Read More
Epix and Schering AG to develop novel MRI agents
Read More
Erbitux manufacturing milestone achieved
Read More
Phase III trials begin for Cerovive in acute ischemic stroke
Read More
Gedeon Richter to market and commercialize Avonex in Central & Eastern Europe
Read More
Salix board recommends rejection of Axcan's revised offer
Read More
High response rates reported for Trisenox in multiple myeloma
Read More
Indications for Viread expanded in E.U.
Read More
Genta reports Genasense clinical results
Read More
OXI-4503 the subject of Oxigene/Cancer Research UK collaboration
Read More
Livial studied for use in breast cancer patients
Read More
Preclinical results for microplasmin in posterior vitreous detachment
Read More